Clinical Trial Update: The Use of 5-ALA in Paediatric Patients With High Grade Brain Tumours [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial at University College London evaluating the use of 5-ALA in pediatric patients with high-grade brain tumors, currently not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Drugs mentioned

• 5-ALA (5-aminolevulinic acid) (5-aminolevulinic acid)

Snippet

Sponsor: University College, London | Conditions: Brain Tumor | Phase 2 | Status: NOT_YET_RECRUITING